APA

Kitakaze M., Hori M., Morioka T., Minamino T., Takashima S., Sato H., Shinozaki Y., Chujo M., Mori H. & Inoue M. (19940614). Alpha 1-adrenoceptor activation mediates the infarct size-limiting effect of ischemic preconditioning through augmentation of 5'-nucleotidase activity. : The Journal of clinical investigation.

Chicago

Kitakaze M, Hori M, Morioka T, Minamino T, Takashima S, Sato H, Shinozaki Y, Chujo M, Mori H and Inoue M. 19940614. Alpha 1-adrenoceptor activation mediates the infarct size-limiting effect of ischemic preconditioning through augmentation of 5'-nucleotidase activity. : The Journal of clinical investigation.

Harvard

Kitakaze M., Hori M., Morioka T., Minamino T., Takashima S., Sato H., Shinozaki Y., Chujo M., Mori H. and Inoue M. (19940614). Alpha 1-adrenoceptor activation mediates the infarct size-limiting effect of ischemic preconditioning through augmentation of 5'-nucleotidase activity. : The Journal of clinical investigation.

MLA

Kitakaze M, Hori M, Morioka T, Minamino T, Takashima S, Sato H, Shinozaki Y, Chujo M, Mori H and Inoue M. Alpha 1-adrenoceptor activation mediates the infarct size-limiting effect of ischemic preconditioning through augmentation of 5'-nucleotidase activity. : The Journal of clinical investigation. 19940614.